Increasing Use of Interferon Gamma Release Assays among Children ≥2 Years of Age in a Setting with Low Tuberculosis Prevalence

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

US guidelines recommend interferon gamma release assays (IGRAs) for diagnosis of tuberculosis infection in children. In this retrospective cohort study, IGRA use in children 2-17 years of age increased substantially between 2015 and 2021. Testing in inpatient/subspecialty settings (vs. primary care), public (vs. private) insurance, lower age and non-English preferred language were associated with increased odds of receiving an IGRA.

Cite

CITATION STYLE

APA

Campbell, J. I., Tabatneck, M., Sun, M., He, W., Musinguzi, N., Hedt-Gauthier, B., … Haberer, J. E. (2022). Increasing Use of Interferon Gamma Release Assays among Children ≥2 Years of Age in a Setting with Low Tuberculosis Prevalence. Pediatric Infectious Disease Journal, 41(12), E534–E537. https://doi.org/10.1097/INF.0000000000003685

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free